Loading...

By Sofía Garduño - Mon, 08/18/2025 - 09:14

The US FDA approves Wegovy to treat adults with MASH and moderate to advanced liver fibrosis, excluding cirrhosis.

Partnership Content

https://mexicobusiness.news/tag/mash

More Health

By MBN Staff - Tue, 11/19/2024 - 09:12

Echosens launches the LHM platform to enhance liver disease care, enabling early detection and better patient outcomes.

By MBN Staff - Tue, 10/15/2024 - 10:07

Boehringer Ingelheim's survodutide gains FDA Breakthrough Therapy designation for MASH, advancing treatment options.